Technical Analysis for SELB - Selecta Biosciences, Inc.

Grade Last Price % Change Price Change
grade F 2.12 3.92% 0.08
SELB closed up 3.92 percent on Thursday, January 17, 2019, on 1.12 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical SELB trend table...

Date Alert Name Type % Chg
Jan 17 Boomer Sell Setup Bearish Swing Setup 0.00%
Jan 17 Narrow Range Bar Range Contraction 0.00%
Jan 17 NR7 Range Contraction 0.00%
Jan 17 Inside Day Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Oversold Stochastic Weakness 0.00%
Jan 16 New 52 Week Closing Low Bearish 3.92%
Jan 16 180 Bearish Setup Bearish Swing Setup 3.92%
Jan 16 Inside Day Range Contraction 3.92%
Jan 16 Wide Bands Range Expansion 3.92%

Older signals for SELB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Selecta Biosciences, Inc., a clinical-stage biotechnology company, develops targeted therapies that use immunomodulators encapsulated in nanoparticles to induce antigen-specific immune responses to prevent and treat disease. The company focus is on developing and commercializing differentiated therapies that are designed to modulate the immune system to effectively and safely treat rare diseases by mitigating the formation of anti-drug antibodies in response to life-sustaining biologic drugs. Its lead product candidate is SEL-212 for the treatment of refractory and chronic tophaceous gout. The company serves customers in the United States and internationally. Selecta Biosciences, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts.
Is SELB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.55
52 Week Low 1.97
Average Volume 217,769
200-Day Moving Average 10.4451
50-Day Moving Average 4.4682
20-Day Moving Average 2.7833
10-Day Moving Average 2.3685
Average True Range 0.4098
ADX 64.86
+DI 5.35
-DI 28.2681
Chandelier Exit (Long, 3 ATRs ) 3.4706
Chandelier Exit (Short, 3 ATRs ) 3.1994
Upper Bollinger Band 3.9086
Lower Bollinger Band 1.658
Percent B (%b) 0.21
BandWidth 80.860849
MACD Line -0.7823
MACD Signal Line -0.8518
MACD Histogram 0.0695
Fundamentals Value
Market Cap 46.8 Million
Num Shares 22.1 Million
EPS -2.87
Price-to-Earnings (P/E) Ratio -0.74
Price-to-Sales 110.08
Price-to-Book 5.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.29
Resistance 3 (R3) 2.27 2.21 2.26
Resistance 2 (R2) 2.21 2.16 2.21 2.25
Resistance 1 (R1) 2.16 2.14 2.19 2.18 2.24
Pivot Point 2.10 2.10 2.11 2.10 2.10
Support 1 (S1) 2.05 2.05 2.08 2.07 2.00
Support 2 (S2) 1.99 2.03 1.99 1.99
Support 3 (S3) 1.94 1.99 1.98
Support 4 (S4) 1.96